Medical Instruments & Supplies
(BAX) Baxter International, Inc. – Growth And Income – Zacks Rank Buy
Baxter International Inc. (BAX) recently declared a quarterly dividend of 26 cents per share, noting that it is payable on April 1 to shareholders of record as of the close of business on March 10.
Company Description
Baxter...
(RMD) ResMed Inc. – Aggressive Growth – Zacks Rank Buy
ResMed, Inc. (RMD) was originally featured as a Zacks Rank Buy in November and has recently announced excellent quarterly results.
Company Description
ResMed...
(BDX) Becton, Dickinson and Company – offers an industry-leading yield of 2%
Becton, Dickinson and Company (BDX) recently declared a quarterly dividend of 33 cents per share, which is payable on March 31 to shareholders of record on March 10. The company offers an industry-leading yield of 2%.
Company Description
Becton, Dickinson and...
(COO) The Cooper Companies – actively cutting costs and focusing on gaining market share
The Cooper Companies, Inc. (COO), which manufactures contact lenses, beat fourth quarter estimates by 12.07% as it recorded record revenue in fiscal 2008. The company has surprised on estimates 3 out of the last 4 quarters by an average of 4.38%. COO is trading at 9.3x forward...
(BAX) Baxter International – ROE of 31% more than doubles the industry average of 12%
Baxter International Inc. (BAX) recently reported record results for 2008, surpassing its guidance. The company also sees double-digit earnings growth in 2009.
Company Description
Baxter International develops, manufactures and markets products that save and...
(THOR) Thoratec Corporation – Earnings per share came in 86% higher than the forecast
Thoratec Corporation (THOR) is coming off of an excellent quarterly announcement that showed a spike in revenue and another earnings surprise. Shares are also benefiting from a newly formed level of support.
Company Description
Thoratec Corporation provides cardiac...
(THOR) Thoratec Corporation – 27% earnings growth projection
Thoratec Corp.’s (THOR) share price has continued to move higher since originally being featured as a momentum stock in early December. A trend line that has been supporting prices for the last 3 months is now being pressured just above $29.
Third-Quarter Results
Thoratec’s...
(RMD) Your Individual Retirement Account (IRA): Resolutions for Wealth & Happiness in 2009
Your Individual Retirement Account (IRA): Resolutions for Wealth & Happiness in 2009
by David Fessler, Advisory Panelist, Investment U
Wednesday, December 31, 2008: Issue #908
Tonight, we look to the New Year and, hopefully, our resolutions...
(VASC) Vascular Solutions – impressive financial profile, ROE of 21% against the industry average of just 2%
Vascular Solutions, Inc.’s (VASC) share price has rebounded after dipping lower in late November. This Zacks #1 rank stock operates in an industry rank #22 out of 217.
Estimates
Analyst estimates have continued to tick higher, with the current-year estimate...
(LMNX) Luminex Corp – next-year estimate pegged at a whopping 359% earnings growth projection
Luminex Corp. (LMNX) is fresh off the heels of a great quarter in which the company swung into profitability from last year. The next-year estimate is extremely bullish and the company’s share price is rallying.
Company Description
Luminex Corp develops...
(CMN) Cantel Medical Corporation – third time in the last three quarters that the company has surprised and beat estimates
Cantel Medical Corp. (CMN) is rallying after reporting another strong quarter in early December. The current-year estimate has been rising for the last few months as analysts anticipate strong earnings growth from the company.
Company Description
Cantel Medical...
(THOR) Thoratec Corporation – handily beat analyst estimates last quarter
Thoratec Corp. (THOR) recently swung into profitability from last year, reporting strong third-quarter results that were fueled by the release of a product that was approved by regulators for sale in April. Estimates are on the move and so is Thoratec’s share price.
Company...
(HRC) Hill-Rom Holdings – beds and furnishings for hospital patient rooms as well as non-invasive therapeutic products for acute and chronic medical conditions
Hill-Rom Holdings Inc. (HRC) reaffirmed 2009 guidance despite the rough economic environment as revenues grew 14.1% in the fourth quarter. HRC surprised on estimates by 7.41% in the fourth quarter. Hill-Rom is trading at 12.8x forward earnings.
Company Description
Hill-Rom...
(RMD) ResMed Inc – PEG ration is 1.1, compared to an industry average of 1.7
ResMed (RMD) announced record quarterly revenues and income. Shares are enticing as they trade at a discount to the industry averages.
Company Description
ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing...
(VASC) Vascular Solutions – optimism is predicated on Vascular’s plans to launch 10 new products
Vascular Solutions, Inc. (VASC) reported a record quarter last week in which net income almost doubled from the same period last year. The company is scheduled to release a number of new products into its domestic and international markets over the next 6 months that it expects...
(BDX) Becton, Dickinson and Company – return on equity (ROE) of 23%, exceeding the industry average of 17%
Becton, Dickinson and Company (BDX) offers a return on equity of 23%, exceeding the industry average of 17%. The company’s dividend yield of 1.7% is also ahead of the industry average as most of BDX’s peers pay no income. BDX is scheduled to release fiscal fourth quarter...
(COV) – Covidien – Sales were up 14% from last year
Covidien Ltd. (COV) has been driving its revenue higher from robust sales in its international markets, which all recorded double-digit sales growth in the most recently reported quarterly results. The next-year estimate is bullish, and the company’s stock price is in...